ANCA-Associated Vasculitides

Table of Contents

1. Altmetric Badge
   Book Overview
2. Altmetric Badge
   Chapter 1 Friedrich Wegener and the Nature of Fame
3. Altmetric Badge
   Chapter 2 Pathogenic Potential of Anti-Neutrophil Cytoplasmic Autoantibodies
4. Altmetric Badge
   Chapter 3 Neutrophilic Leukocyte Granules: From Structure to Function
5. Altmetric Badge
   Chapter 4 Pathogenetic Aspects of Autoantibodies to Endothelial Cells in Systemic Vasculitis
6. Altmetric Badge
   Chapter 5 Membrane Surface Proteinase 3 Expression and Intracytoplasmic Immunoglobulin on Neutrophils from Patients with ANCA-Associated Vasculitides
7. Altmetric Badge
   Chapter 6 A New Approach to the Molecular Characterization of the C-ANCA Antigen in Wegener’s Granulomatosis
8. Altmetric Badge
   Chapter 7 Proteinase 3: Substrate Specificity and Possible Pathogenetic Effect of Wegener’s Granulomatosis Autoantibodies (C-ANCA) by Dysregulation of the Enzyme
9. Altmetric Badge
   Chapter 8 Inhibition of Proteinase 3 Activity by Peptides Derived from Human Epidermis
10. Altmetric Badge
    Chapter 9 Implications of c-ANCA Testing for the Classification of Wegener’s Granulomatosis: Performance of Different Detection Systems
11. Altmetric Badge
    Chapter 10 ANCA and IgG Subclasses
12. Altmetric Badge
    Chapter 11 Anti-MPO Antibody (Id) and Autoantibody to Purified Anti-MPO F(Ab)2 (Anti-Id)
13. Altmetric Badge
    Chapter 12 Cross-Reactivity between Antibodies to Thyroid Microsomal Antigens and Myeloperoxidase
14. Altmetric Badge
    Chapter 13 Antineutrophil Cytoplasmic Autoantibodies (ANCA) Recognizing a Recombinant Myeloperoxidase Subunit
15. Altmetric Badge
    Chapter 14 Pooled Human IgG (PHIG) Inhibits the Binding of Anti-Myeloperoxidase Antibodies to Myeloperoxidase
16. Altmetric Badge
    Chapter 15 Studies to demonstrate inhibition of functional activity of neutrophil lysosomal enzymes with ANCA.
17. Altmetric Badge
    Chapter 16 Lactoferrin Co-Purifies with Myeloperoxidase and is Recognised by Anti-Neutrophil Cytoplasm Antibodies
18. Altmetric Badge
    Chapter 17 ANCA specificities for HL-60 and neutrophil constituents.
19. Altmetric Badge
    Chapter 18 In Vitro Interactions of C-ANCA (Antibodies to Proteinase 3) with Human Endothelial Cells
20. Altmetric Badge
    Chapter 19 Anti-neutrophil cytoplasm antibodies (ANCA) increase neutrophil adhesion to cultured human endothelium.
21. Altmetric Badge
    Chapter 20 Myeloperoxidase Binds to Vascular Endothelial Cells, is Recognized by ANCA and can Enhance Complement Dependent Cytotoxicity
22. Altmetric Badge
    Chapter 21 Vascular Permeability Changes Induced by Antibodies to Myeloperoxidase
23. Altmetric Badge
    Chapter 22 Endothelium, Myeloperoxidase, Anti-Myeloperoxidase Interaction in Vasculitis
24. Altmetric Badge
    Chapter 23 Further Characterization of an Animal Model of Systemic Vasculitis
25. Altmetric Badge
    Chapter 24 Induction of an Humoral and Cellular (Auto) Immune Response to Human and Rat Myeloperoxidase(MPO) in Brown-Norway(BN), Lewis and Wistar Kyoto(WKY) Rat Strains
26. Altmetric Badge
    Chapter 25 Disease associations with anti-neutrophil cytoplasmic antibodies.
27. Altmetric Badge
    Chapter 26 Classification of Vasculitis
28. Altmetric Badge
    Chapter 27 Classification of Systemic Vasculitis — A Pathologist’s View
29. Altmetric Badge
    Chapter 28 Polyarteritis Nodosa and Churg-Strauss Syndrome an Internist’s View
30. Altmetric Badge
    Chapter 29 Vasculitis from the Rheumatologist’s Viewpoint
31. Altmetric Badge
    Chapter 30 A Nephrological View of the Classification of Vasculitis
32. Altmetric Badge
    Chapter 31 The Nosology of Wegener’s Granulomatosis Utilizing the Elk Format Augmented by C-ANCA
33. Altmetric Badge
    Chapter 32 Vasculitis — The Neurologist’s View
34. Altmetric Badge
    Chapter 33 Treatment of Chronic Idiopathic Systemic Vasculitides
35. Altmetric Badge
    Chapter 34 Monoclonal Antibody Therapy for Vasculitis
36. Altmetric Badge
    Chapter 35 Heterogeneity of ANCA sera showing atypical, peripheral and classical cytoplasmic immunofluorescence patterns.
37. Altmetric Badge
    Chapter 36 ANCA in Systemic Vasculitides, Collagen Vascular Diseases, Rheumatic Disorders and Inflammatory Bowel Diseases
38. Altmetric Badge
    Chapter 37 Perinuclear Antineutrophil Cytoplasmic Antibodies (P-ANCA): Clinical Significance and Relation to Antibodies Against Myeloid Lysosomal Enzymes
39. Altmetric Badge
    Chapter 38 Methods of Detection of Anticathepsin G Autoantibodies in Human
40. Altmetric Badge
    Chapter 39 Anti-Myeloperoxidase Antibodies and Associated Diseases
41. Altmetric Badge
    Chapter 40 Autoantibodies Directed Against Lysozyme: A New Target Antigen for Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
42. Altmetric Badge
    Chapter 41 Clinical Significance of ANCA in 98 Patients
43. Altmetric Badge
    Chapter 42 Anti-Neutrophil Cytoplasmic Autoantibodies (ANCA): Antigenic Specificities and Clinical Associations
44. Altmetric Badge
    Chapter 43 Significance of Autoantibodies to Purified Proteinase 3 in Systemic Vasculitis
45. Altmetric Badge
    Chapter 44 Characterization of Anti-Myeloperoxidase Antibodies in Vasculitis
46. Altmetric Badge
    Chapter 45 Low Predictive Value of C-ANCA and Anti-α -Granule Antibody for Vasculitis in Hong Kong
47. Altmetric Badge
    Chapter 46 Detection and Clinical Associations of Autoantibodies to Myeloid Granular Proteins
48. Altmetric Badge
    Chapter 47 Relationship Between Disease Activity and ANCA Level by Elisa in the Long-Term Management of Vasculitis
49. Altmetric Badge
    Chapter 48 ANCA in Ocular Inflammatory Disorders
50. Altmetric Badge
    Chapter 49 Head and Neck Involvement in Wegener’s Granulomatosis (WG)
51. Altmetric Badge
    Chapter 50 Orbital Involvement in Wegener’s Granulomatosis
52. Altmetric Badge
    Chapter 51 MRI of the Head in Wegener’s Granulomatosis
53. Altmetric Badge
    Chapter 52 The Clinical, Serologic, and Immunopathologic Heterogeneity of Cutaneous Leukocytoclastic Angiitis
54. Altmetric Badge
    Chapter 53 No ANCA in Thromboangiitis Obliterans (Bürger’s Disease)
55. Altmetric Badge
    Chapter 54 Alpha-1-Proteinase Inhibitor and Pulmonary Haemorrhage in Systemic Vasculitis
56. Altmetric Badge
    Chapter 55 Alpha-1-Antitrypsin, CRP and Interleukin-6 in ANCA-positive Vasculitis
57. Altmetric Badge
    Chapter 56 Pro- and Anti-Inflammatory Cytokines in Primary Systemic Vasculitis
58. Altmetric Badge
    Chapter 57 Problems of Classification in Necrotizing Vasculitis
59. Altmetric Badge
    Chapter 58 Anti-neutrophil cytoplasm antibodies in HIV infection.
60. Altmetric Badge
    Chapter 59 Anti-Neutrophil Cytoplasmic Antibodies (ANCA) and Infection
61. Altmetric Badge
    Chapter 60 Anti-Lactoferrin Antibodies in Patients with Rheumatoid Arthritis with Vasculitis
62. Altmetric Badge
    Chapter 61 Anti-Neutrophil Cytoplasmic Antibodies in Giant Cell Arteritis and Polymyalgia Rheumatica
63. Altmetric Badge
    Chapter 62 Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritis.
64. Altmetric Badge
    Chapter 63 Incidence and Specificity of p-ANCA in Rheumatic Diseases
65. Altmetric Badge
    Chapter 64 Anti-Granulocyte Perinuclear Antibodies but Not Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Rheumatoid Arthritis
66. Altmetric Badge
    Chapter 65 Anti-Neutrophil Cytoplasmic Antibodies in Patients with Systemic Lupus Erythematosus
67. Altmetric Badge
    Chapter 66 ANCA with Specificity for Lactoferrin in Systemic Lupus Erythematosus (SLE)
68. Altmetric Badge
    Chapter 67 Serum Markers of T-Cell Activation in Relapses of Wegener’s Granulomatosis
69. Altmetric Badge
    Chapter 68 Presence of Anticardiolipin Antibodies Discriminates Between Wegener’s Granulomatosis and Microscopic Polyarteritis
70. Altmetric Badge
    Chapter 69 Increased Expression of CD 25 and Adhesion Molecules on Peripheral Blood Lymphocytes of Patients with Wegener’s Granulomatosis (WG) and ANCA Positive Vasculitides
71. Altmetric Badge
    Chapter 70 Wegener’s Granulomatosis with Severe Peripheral and Central Neuropathy — Case Report
72. Altmetric Badge
    Chapter 71 Limited Prognostic Value of Changes in Antineutrophil Cytoplasmic Antibody Titers in Patients with Wegener’s Granulomatosis
73. Altmetric Badge
    Chapter 72 Wegener’s Granulomatosis and Henoch-Schönlein Purpura in a Family with Hereditary C4 Deficiency
74. Altmetric Badge
    Chapter 73 Little Evidence for Anti-Endothelial-Cell Antibodies in Microscopic Polyarteritis and Wegener’s Granulomatosis
75. Altmetric Badge
    Chapter 74 Prevalence of ANCAs in Patients on Maintenance Haemodialysis
76. Altmetric Badge
    Chapter 75 Rhabdomyolysis in Vasculitis
77. Altmetric Badge
    Chapter 76 Rapidly Progressive Glomerulonephritis (RPGN): Is there Still an “Idiopathic” Subgroup?
78. Altmetric Badge
    Chapter 77 Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study.
79. Altmetric Badge
    Chapter 78 ANCA and Anti-GBM Antibodies in RPGN
80. Altmetric Badge
    Chapter 79 P-ANCA with Myeloperoxidase Antibodies and C-ANCA with Proteinase 3 Antibodies Define a Different Vasculitis Entity in Patients with Renal Involvement
81. Altmetric Badge
    Chapter 80 Antineutrophil-Cytoplasmic-Autoantibodies in Poststreptococcal Nephritis
82. Altmetric Badge
    Chapter 81 Indentification of Apparent Dual ANCA Specificities in a Subset of Patients with Systemic Vasculitis and Crescentic Glomerulonephritis
83. Altmetric Badge
    Chapter 82 C-ANCA and p-ANCA Positive Vasculitis with Crescentic Glomerulonephritis: The Same Clinical Feature but Different Immunological Pathways ?
84. Altmetric Badge
    Chapter 83 Clinical Manifestations in Patients on Chronic Dialysis with High Titres of ANCA
85. Altmetric Badge
    Chapter 84 Pooled intravenous immunoglobulin in the management of systemic vasculitis.
86. Altmetric Badge
    Chapter 85 Cyclosporin A therapy for Wegener's granulomatosis.
87. Altmetric Badge
    Chapter 86 Necrotizing Vasculitis — Relapse Despite Cytotoxic Therapy
88. Altmetric Badge
    Chapter 87 Effectiveness of Cyclophosphamide Pulse Treatment in Wegener’s Granulomatosis
89. Altmetric Badge
    Chapter 88 Treatment of Wegener’s Granulomatosis with Intravenous Immunoglobulin
90. Altmetric Badge
    Chapter 89 Treatment of Wegener’s Granulomatosis
91. Altmetric Badge
    Chapter 90 Treatment Modalities and ANCA in Takayasu’s Arteritis
92. Altmetric Badge
    Chapter 91 Late Recurrence of Systemic Vasculitis after Kidney Transplantation Involving the Kidney Allograft
93. Altmetric Badge
    Chapter 92 p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy.
94. Altmetric Badge
    Chapter 93 Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study.
95. Altmetric Badge
    Chapter 94 Antineutrophil antibodies in inflammatory bowel disease recognize different antigens.
96. Altmetric Badge
    Chapter 95 Antineutrophil cytoplasmic auto-antibodies in sera from patients with ulcerative colitis after proctocolectomy with ileo-anal anastomosis.
97. Altmetric Badge
    Chapter 96 p-ANCA as a diagnostic marker in ulcerative colitis.
98. Altmetric Badge
    Chapter 97 Lactoferrin, anti-lactoferrin antibodies and inflammatory disease.
99. Altmetric Badge
    Chapter 98 Detection of Antineutrophil Cytoplasmatic Antibodies (ANCA) and their Association with other Autoantibodies in Patients with Hepatobiliary Disorders
100. Altmetric Badge
     Chapter 99 Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease.